Chidozie Ugwumba sold $73k of CLNN
owner at Clene Inc.. 11,671 shares at an average of $6.28, traded Dec 23, 2025, filed Dec 30, 2025.
Score components
- +12Role10% owner
- +8Trade size$73k at market
- 0Share of holdings soldSold 1.4% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001835544-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | EExpiration of short derivative Common Stockindirect: By Symbiosis II, LLC | +424,358 | $0.00 | $424 | 807,495 | Dec 30, 2025 |
| Dec 23, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -6,831 | $6.27 | $43k | 800,664 | Dec 30, 2025 |
| Dec 24, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -1,490 | $6.27 | $9,342 | 799,174 | Dec 30, 2025 |
| Dec 26, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -3,350 | $6.32 | $21k | 795,824 | Dec 30, 2025 |
| Dec 23, 2025 | EExpiration of short derivative Pre-Funded Warrant to Purchase Common Stockderivativeindirect: By Symbiosis II, LLC | -424,358 | $4.59 | $1.9M | 0 | Dec 30, 2025 |
Related signals
Other insiders at Clene Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $494k 100,997 shares | -19% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $100k 17,909 shares | -3% | |
| 12Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $23k 5,559 shares | -1% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $105k 24,770 shares | -4% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $96k 19,274 shares | -3% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $97k 18,221 shares | -3% | |
| 23Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $162k 32,474 shares | -5% | |
| 26Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $292k 58,289 shares | -8% | |
| 38Weak | CLNNbuy Clene Inc. | David J Matlin director | $217k 33,333 shares | +7% | |
| 25Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $256k 44,975 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.